SEARCH RESULTS

2 RESULTS

Joel Buxbaum on BRI2 (ITM2b) inhibits Abeta deposition in vivo.

COMMENT There are between 50 and 100 experimental manipulations that have been shown to alter the pathologic and/or behavioral phenotypes of various transgenic models of human Alzheimer disease. The description in this paper of the effect of the Bri protein, the ...

Current Filters

  • TYPE: Comment x
  • Commentator: Buxbaum, Joel x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE